- Product
- This situation of mixing Lyrica with other doses is absurd
- by Kang, Shin-Kook Mar 22, 2021 06:16am
- When it was confirmed that Pfizer Korea's Lyrica had mixed drugs with different doses, The Korean Pharmaceutical Association urged a countermeasure to prevent recurrence. The KPA(Chairman Dae-eop Kim) made a statement on the 17th, saying, "The case where different doses of pharmaceuticals are mixed & packaging in the bottle is a serious prob
- Product
- KMA recommends Tylenol for fever after AZ vaccination
- by Kang, Shin-Kook Mar 10, 2021 06:26am
- After the AstraZeneca COVID-19 vaccination, the frequency of fever or muscle pain was found to be 20-30%, and the KMA recommended taking Tylenol. The KMA (Chairman Choi Daejip) released a recommendation containing countermeasures after the COVID-19 vaccine vaccination to the public on the 6th. The KMA said, "In the case of the AstraZenec
- Product
- Frequently consumed OTC drug prices differ in pharmacies
- by Kang, Shin-Kook Feb 3, 2021 06:09am
- The price gap of Tyrenol ER, Gelfos and Tak-Sen widened up to 150 percent among different pharmacies selling the drugs, which contrasted against high-priced bundle-packaged drugs showing barely any gap. Daily Pharm surveyed 22 pharmacies in Incheon for their frequently sold over-the-counter (OTC) drug retail prices as of February, and it fou
- Product
- Efficacy vs. More inoculation? Vaccination plan in dilemma
- by Choi-sun Jan 22, 2021 06:26am
- The public is questioning the actual efficacy of the alternative regimen of the COVID-19 vaccine that reduces dose or delays the booster dose due to the vaccine shortage, Relevant experts give conflicted opinions. Some argue the government should maximize the efficacy with the limited resource, whereas some claim medical evidence is integral
- Product
- What are the latest COVID-19 drug guidelines?
- by Choi, sun Jan 8, 2021 06:19am
- As COVID-19 pandemic has passed a year, the guidelines for drug use are being updated a lot. As the evidence was accumulated, the differences in the guidelines for use by each country decreased, and detailed recommendations for practical use were derived with recommendations for use and refraining from various cases even with the same drug.
- Product
- “The lower the income, the later the cancer diagnosis”
- by Eo, Yun-Ho Dec 16, 2020 06:13am
- A survey found a clear correlation between the income level and the level of tumor development and metastasis when a patient with cancer is diagnosed. A not-for-profit organization advocating the improvement in inefficiency in cancer treatment environment, ‘All.Can Korea’ kicked off on Dec. 10 and disclosed a survey result on 495 canc
- Product
- Instructing Tamiflu users on neurological side effect
- by Kang, Shin-Kook Dec 11, 2020 06:14am
- “Have you heard of that incident two years ago, where a middle school student took a fall after taking Tamiflu?” The importance of influenza treatment administration instruction is reiterated due to the reported neurological adverse reaction after the administration. On Dec. 9, the Korean Pharmaceutical Association (KPA) notified a
- Product
- What’s it like to have ATTR-CM in Korea
- by won, jong-hyuk Dec 10, 2020 06:09am
- A few years ago, a 50-year-old man visited a hospital when he experienced shortness of breath and edema. But he had to visit a number of hospitals for years for examination as he struggled to pin point the name of the disease. And one day, he felt tingling sensation in his toes and examined the heart. That was the time he had to face his rar
- Product
- COVID-19 vaccine almost there, how about cost-effectiveness?
- by Choi,sun Dec 7, 2020 06:05am
- The anticipation for the COVID-19 vaccines in development is soaring as a number of global pharmaceutical companies have announced successful clinical trial results. The health authority and the public would closely follow the vaccines’ further development to confirm their effect, safety and reasonable pricing. ▲The COVID-19 vaccine
- Product
- High risk in bone fracture found with long-term GCs use
- by Lee, in-bok Nov 30, 2020 06:20am
- A study claims a long-term prescription of glucocorticoid (GCs) could raise the risk of osteoporosis and bone fracture even in South Koreans. The researchers found the bone density dips significantly and the risk goes up high three months into the prescription. So far, there were studies condudcted in the U.S. and Europe warning such risks,
